Treatment strategy for a multidrug-resistant Klebsiella UTI.

about

Immunity to uropathogens: the emerging roles of inflammasomes.

P2860

Q39165446-84AFF7FA-3050-4DC8-807A-D924DA38D64A

P2860

Treatment strategy for a multidrug-resistant Klebsiella UTI.

Item

http://www.wikidata.org/entity/Q39310965

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@en

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@nl

type

Item

label

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@en

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@nl

prefLabel

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@en

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@nl

P1476

Treatment strategy for a multidrug-resistant Klebsiella UTI.

@en

P2093

Emily L Heil

http://www.w3.org/2001/XMLSchema#string

Erin Fleming

http://www.w3.org/2001/XMLSchema#string

Lauren M Hynicka

http://www.w3.org/2001/XMLSchema#string

P2860

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

Polymyxins: Antimicrobial susceptibility concerns and therapeutic options

Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates

Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula.

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.

Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens.

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

Urinary tract infections in patients with chronic renal insufficiency.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

P304

123-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028013509974

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24259631

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

Treatment strategy for a multidrug-resistant Klebsiella UTI.

about

P2860

P2860

Treatment strategy for a multidrug-resistant Klebsiella UTI.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921